Table of Contents
Introduction: Brain Optimization vs Metabolic Enhancement
Semax and MOTS-c are both peptides with enhancement potential, but they target entirely different biological systems. Semax is a synthetic ACTH analog that enhances brain function through BDNF and neurotransmitter modulation. MOTS-c is a mitochondrial-derived peptide that improves metabolic function through AMPK activation and mitochondrial biogenesis. One optimizes the brain; the other optimizes cellular energy metabolism.
Semax: BDNF-Driven Cognitive Enhancement
Semax enhances cognitive function through BDNF upregulation in hippocampus and cortex, dopamine and serotonin system modulation, neuroprotection against ischemic damage, and gene expression changes in 100+ brain-relevant genes. Delivered intranasally for direct CNS access. Approved in Russia for stroke recovery and cognitive impairment.
MOTS-c: Mitochondrial-Derived Metabolic Peptide
MOTS-c is a 16-amino-acid peptide encoded by the mitochondrial genome (12S rRNA gene). Discovered by Dr. Changhan David Lee’s lab at USC in 2015, it is the first mitochondrial-derived peptide shown to regulate nuclear gene expression (PMID: 25738459).
- AMPK activation: Activates AMP-activated protein kinase — the cellular energy sensor
- Glucose metabolism: Improves insulin sensitivity and glucose uptake
- Mitochondrial function: Enhances mitochondrial biogenesis and respiratory chain efficiency
- Fat metabolism: Promotes fatty acid oxidation
- Exercise mimetic: Replicates some molecular benefits of physical exercise
- Aging: Circulating MOTS-c levels decline with age, correlating with metabolic decline
Mechanism Comparison
| Feature | Semax | MOTS-c |
|---|---|---|
| Origin | Synthetic ACTH(4-10) analog | Mitochondrial genome (12S rRNA) |
| Primary Target | Brain (neurotrophins) | Metabolism (AMPK, mitochondria) |
| Key Pathway | BDNF ? synaptic plasticity | AMPK ? metabolic homeostasis |
| Cognitive Effects | Direct (learning, memory, attention) | Indirect (better energy ? better brain function) |
| Metabolic Effects | Minimal | Primary (glucose, fat, insulin sensitivity) |
| Administration | Intranasal | Injectable |
| Clinical Status | Approved in Russia | Research compound (USC discovery) |
Choosing the Right Peptide
Choose Semax when:
- Cognitive enhancement or neuroprotection is the research focus
- BDNF biology and synaptic plasticity are the research questions
- Stroke recovery or ischemic brain models are being used
- Brain-targeted intranasal delivery is preferred
Choose MOTS-c when:
- Metabolic health (glucose, insulin, fat metabolism) is the focus
- Exercise mimetic effects are being studied
- Mitochondrial biology and AMPK signaling are endpoints
- Aging-related metabolic decline is the research model
- The study involves obesity, diabetes, or metabolic syndrome
For metabolic fat loss research, MOTS-c can be compared with SLU-PP-332 (exercise mimetic via ERR?), AOD 9604 (GH fragment lipolysis), or Semaglutide (GLP-1 appetite/metabolism).
Frequently Asked Questions
Can Semax and MOTS-c be combined?
Yes. They target completely different systems — Semax works on brain neurotrophic signaling while MOTS-c works on metabolic and mitochondrial pathways. A combination could optimize both cognitive function (Semax) and metabolic health (MOTS-c), which could be particularly interesting in aging research where both systems decline simultaneously.
What is the best nootropic peptide Proxiva Labs sells?
Semax is the most directly nootropic peptide in our catalog, with BDNF upregulation, clinical approval in Russia, and demonstrated cognitive enhancement in research models. For broader neuroprotection that includes tissue healing, BPC-157 offers dopaminergic protection and nerve regeneration alongside its systemic healing properties.
Does MOTS-c help with brain function?
Indirectly, yes. MOTS-c improves mitochondrial function and cellular energy metabolism, and neurons are the most energy-demanding cells in the body. Improved mitochondrial function could support better neuronal energy supply and cognitive performance. However, MOTS-c is not a nootropic — it does not directly modulate neurotransmitters or neurotrophic factors like Semax does.
References
- Dolotov OV, et al. Semax, an analogue of ACTH(4-10), regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60.
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459
- Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.
About Proxiva Labs: We supply research-grade Semax for cognitive research and MOTS-c for metabolic research. Also: SLU-PP-332, AOD 9604, Semaglutide. Browse the complete research peptide catalog.
All products are sold strictly for research purposes only. Not for human consumption.
